In January 2023, Mark Lewis, MD, stood with the door slammed in his face. His partner in the practice had had enough. She ...
Two fifths of oncology drugs approved by the EMA over the past 25 years don't offer an added benefit, while their costs may ...
Posttraumatic epilepsy was associated with a significantly higher risk for long-term dementia compared with no history of ...
The use of cannabis showed a statistically significant association with adverse cardiovascular outcomes independent of ...
Physicians' negative online reviews — fair or unfair — can scare away new patients. But practices don't have to sit idly by ...
Emerging evidence suggests that oral health, often overlooked by clinicians, is closely connected with overall health — and ...
Longer-acting drugs, novel implants, and oral and topical agents that aim to solve the burden of frequent injections and ...
A large language model (LLM) chatbot demonstrated proficiency in ophthalmology, matching or outperforming specialists in the ...
Women remain underrepresented in interventional specialties, and reaching female medical students who might consider these ...
The US Food and Drug Administration (FDA) has approved omalizumab injection (Xolair, Genentech) for children aged 1 year or ...
COVID-19–related cognitive deficits in severe cases were equivalent to a 9-point drop in IQ, new data show, with most ...
Survivors of COVID-19−associated acute kidney injury (COVID-AKI) are less likely to experience long-term kidney effects than ...